Moderna Has Been on FIRE. But Is it Still a Buy?
Is Moderna still a buy?
I’ve been hearing this question a lot this month. Probably my most popular video I’ve done since joining the team here at WealthPress was a few weeks ago when I said Moderna could double or triple this year. It seemed bold to some, but we’re getting close to doubling already!
My first video was posted back on Jan. 5 when Moderna Inc. (Nasdaq: MRNA) was trading under $110.
Since that day, I have been bombarded by great questions about this vaccine company. Shares have quickly marched higher, exploding after hours heading into Friday, rising from $159 to as high as $183.86-and-change shortly after the opening bell.
The market tanked and the stock still closed above $173 Friday, good for about a 60% bump in 24 days!
For some background, Moderna was down about 40% off recent highs in early January. Based on 2021 earnings-per-share estimates from analysts, the stock’s valuation just looked way too low.
But Is Moderna Still a Buy?
WealthPress’ Jeff Yastine
So here we are, a few weeks later, and we’re sitting 60% higher. So now of course the question I keep getting since shares are back near their all-time highs… is it still a good time to get in?
If this past week’s activity — amid the GameStop short-squeeze mania — shows us anything, it’s that everything in the stock market carries risk. There are periods that seem like there’s hardly any risk. But before you know it there’s a sharp correction…
And sometimes bear markets, which introduce a whole new generation to the fact that sometimes, you can lose money. And that’s why investing and speculating tends to be hard. And if it seems easy, that’s only because the market makes it seem easy when everything is going up.
So the question we’ll answer in today’s video is whether not Moderna is still a buy. Let us know your thoughts in the comments below.
And as always, send your investing questions to jeff@yastine.com. Be sure to subscribe to my new YouTube channel. You can also follow me on Twitter and Facebook.
The little guys are leading a charge against Wall Street…
And could open up opportunities to strike it rich — even if you aren’t an expert!
For the first time in trading history, the balance of power has swung in another direction. Retail investors could have just as much potential to move the markets as Wall Street veterans.
The Robinhood Effect could forge a new path for everyday traders and I want you to get a slice of the pie, too. That’s why I’m revealing exactly how you could make the most of this opportunity… and more.
2 Comments
I bought Moderna (MRNA) shares on May 20, 2020 with my first stimulus check. I believe it was trading at $43 per share. It has done extremely well. I am riding the roller coaster still holding to Moderna.
I read your article a few weeks ago calling Moderna a value play. I bought at 103 i think, just sold yesterday at 173. That is about 67% return just from reading your article. I don’t think I held it more than 3 weeks. I don’t know you personally but I love you man! Thank you.